Industry: Medical Devices & Consumables
Published Date: 2024-12-26
Pages: 128 Pages
Report ld: 3410686
Request Sample
Customized Report
Stented Tissue Heart Valve Market Size(US$)

CAGR 2024-2030
9%
Market Size,2030
USD 584
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Valued at US$ 348 million in 2024, the global Stented Tissue Heart Valve market is forecast to reach US$ 584 million by 2030, at a CAGR of 9.0% during the forecast period.
Stented Tissue Heart Valves are biologic valves that are made of animal tissue, usually porcine or bovine pericardium or valve tissue, and fixed to a metal or synthetic scaffold and are used to replace diseased heart valves in patients to improve hemodynamic function and reduce the risk of valve-related complications. This valve is designed to provide long-term, stable flow control during heart valve replacement surgery and to mimic the function of a native valve.
The US & Canada market for Stented Tissue Heart Valve is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Stented Tissue Heart Valve is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Stented Tissue Heart Valve is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Stented Tissue Heart Valve include Medtronic, Abbott, Edwards Lifesciences, LivaNova, Braile Biomedica, CryoLife, Inc, Meril Life Sciences Pvt. Ltd, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Stented Tissue Heart Valve, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Stented Tissue Heart Valve, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Stented Tissue Heart Valve, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Stented Tissue Heart Valve sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Stented Tissue Heart Valve market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Stented Tissue Heart Valve sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Abbott, Edwards Lifesciences, LivaNova, Braile Biomedica, CryoLife, Inc, Meril Life Sciences Pvt. Ltd, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Stented Tissue Heart Valve in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Stented Tissue Heart Valve manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stented Tissue Heart Valve sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Stented Tissue Heart Valve Product Introduction
1.2 Market by Type
1.2.1 Global Stented Tissue Heart Valve Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Aortic-valve Replacement
1.2.3 Mitral-valve Replacement
1.3 Market by Application
1.3.1 Global Stented Tissue Heart Valve Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Stented Tissue Heart Valve Revenue Estimates and Forecasts 2019-2030
2.2 Global Stented Tissue Heart Valve Revenue by Region
2.2.1 Global Stented Tissue Heart Valve Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Stented Tissue Heart Valve Revenue by Region (2019-2024)
2.2.3 Global Stented Tissue Heart Valve Revenue by Region (2025-2030)
2.2.4 Global Stented Tissue Heart Valve Revenue Market Share by Region (2019-2030)
2.3 Global Stented Tissue Heart Valve Sales Estimates and Forecasts 2019-2030
2.4 Global Stented Tissue Heart Valve Sales by Region
2.4.1 Global Stented Tissue Heart Valve Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Stented Tissue Heart Valve Sales by Region (2019-2024)
2.4.3 Global Stented Tissue Heart Valve Sales by Region (2025-2030)
2.4.4 Global Stented Tissue Heart Valve Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Stented Tissue Heart Valve Sales by Manufacturers
3.1.1 Global Stented Tissue Heart Valve Sales by Manufacturers (2019-2024)
3.1.2 Global Stented Tissue Heart Valve Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Stented Tissue Heart Valve in 2023
3.2 Global Stented Tissue Heart Valve Revenue by Manufacturers
3.2.1 Global Stented Tissue Heart Valve Revenue by Manufacturers (2019-2024)
3.2.2 Global Stented Tissue Heart Valve Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Stented Tissue Heart Valve Revenue in 2023
3.3 Global Key Players of Stented Tissue Heart Valve, Industry Ranking, 2021 VS 2022
3.4 Global Stented Tissue Heart Valve Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Stented Tissue Heart Valve Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Stented Tissue Heart Valve, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Stented Tissue Heart Valve, Product Offered and Application
3.8 Global Key Manufacturers of Stented Tissue Heart Valve, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Stented Tissue Heart Valve Sales by Type
4.1.1 Global Stented Tissue Heart Valve Historical Sales by Type (2019-2024)
4.1.2 Global Stented Tissue Heart Valve Forecasted Sales by Type (2025-2030)
4.1.3 Global Stented Tissue Heart Valve Sales Market Share by Type (2019-2030)
4.2 Global Stented Tissue Heart Valve Revenue by Type
4.2.1 Global Stented Tissue Heart Valve Historical Revenue by Type (2019-2024)
4.2.2 Global Stented Tissue Heart Valve Forecasted Revenue by Type (2025-2030)
4.2.3 Global Stented Tissue Heart Valve Revenue Market Share by Type (2019-2030)
4.3 Global Stented Tissue Heart Valve Price by Type
4.3.1 Global Stented Tissue Heart Valve Price by Type (2019-2024)
4.3.2 Global Stented Tissue Heart Valve Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Stented Tissue Heart Valve Sales by Application
5.1.1 Global Stented Tissue Heart Valve Historical Sales by Application (2019-2024)
5.1.2 Global Stented Tissue Heart Valve Forecasted Sales by Application (2025-2030)
5.1.3 Global Stented Tissue Heart Valve Sales Market Share by Application (2019-2030)
5.2 Global Stented Tissue Heart Valve Revenue by Application
5.2.1 Global Stented Tissue Heart Valve Historical Revenue by Application (2019-2024)
5.2.2 Global Stented Tissue Heart Valve Forecasted Revenue by Application (2025-2030)
5.2.3 Global Stented Tissue Heart Valve Revenue Market Share by Application (2019-2030)
5.3 Global Stented Tissue Heart Valve Price by Application
5.3.1 Global Stented Tissue Heart Valve Price by Application (2019-2024)
5.3.2 Global Stented Tissue Heart Valve Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Stented Tissue Heart Valve Market Size by Type
6.1.1 US & Canada Stented Tissue Heart Valve Sales by Type (2019-2030)
6.1.2 US & Canada Stented Tissue Heart Valve Revenue by Type (2019-2030)
6.2 US & Canada Stented Tissue Heart Valve Market Size by Application
6.2.1 US & Canada Stented Tissue Heart Valve Sales by Application (2019-2030)
6.2.2 US & Canada Stented Tissue Heart Valve Revenue by Application (2019-2030)
6.3 US & Canada Stented Tissue Heart Valve Market Size by Country
6.3.1 US & Canada Stented Tissue Heart Valve Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Stented Tissue Heart Valve Revenue by Country (2019-2030)
6.3.3 US & Canada Stented Tissue Heart Valve Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Stented Tissue Heart Valve Market Size by Type
7.1.1 Europe Stented Tissue Heart Valve Sales by Type (2019-2030)
7.1.2 Europe Stented Tissue Heart Valve Revenue by Type (2019-2030)
7.2 Europe Stented Tissue Heart Valve Market Size by Application
7.2.1 Europe Stented Tissue Heart Valve Sales by Application (2019-2030)
7.2.2 Europe Stented Tissue Heart Valve Revenue by Application (2019-2030)
7.3 Europe Stented Tissue Heart Valve Market Size by Country
7.3.1 Europe Stented Tissue Heart Valve Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Stented Tissue Heart Valve Revenue by Country (2019-2030)
7.3.3 Europe Stented Tissue Heart Valve Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Stented Tissue Heart Valve Market Size by Type
8.1.1 China Stented Tissue Heart Valve Sales by Type (2019-2030)
8.1.2 China Stented Tissue Heart Valve Revenue by Type (2019-2030)
8.2 China Stented Tissue Heart Valve Market Size by Application
8.2.1 China Stented Tissue Heart Valve Sales by Application (2019-2030)
8.2.2 China Stented Tissue Heart Valve Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Stented Tissue Heart Valve Market Size by Type
9.1.1 Asia Stented Tissue Heart Valve Sales by Type (2019-2030)
9.1.2 Asia Stented Tissue Heart Valve Revenue by Type (2019-2030)
9.2 Asia Stented Tissue Heart Valve Market Size by Application
9.2.1 Asia Stented Tissue Heart Valve Sales by Application (2019-2030)
9.2.2 Asia Stented Tissue Heart Valve Revenue by Application (2019-2030)
9.3 Asia Stented Tissue Heart Valve Market Size by Region
9.3.1 Asia Stented Tissue Heart Valve Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Stented Tissue Heart Valve Revenue by Region (2019-2030)
9.3.3 Asia Stented Tissue Heart Valve Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Stented Tissue Heart Valve Market Size by Type
10.1.1 Middle East, Africa and Latin America Stented Tissue Heart Valve Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Stented Tissue Heart Valve Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Stented Tissue Heart Valve Market Size by Application
10.2.1 Middle East, Africa and Latin America Stented Tissue Heart Valve Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Stented Tissue Heart Valve Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Stented Tissue Heart Valve Market Size by Country
10.3.1 Middle East, Africa and Latin America Stented Tissue Heart Valve Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Stented Tissue Heart Valve Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Stented Tissue Heart Valve Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Medtronic Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Overview
11.2.3 Abbott Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbott Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Edwards Lifesciences
11.3.1 Edwards Lifesciences Company Information
11.3.2 Edwards Lifesciences Overview
11.3.3 Edwards Lifesciences Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Edwards Lifesciences Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Edwards Lifesciences Recent Developments
11.4 LivaNova
11.4.1 LivaNova Company Information
11.4.2 LivaNova Overview
11.4.3 LivaNova Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 LivaNova Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LivaNova Recent Developments
11.5 Braile Biomedica
11.5.1 Braile Biomedica Company Information
11.5.2 Braile Biomedica Overview
11.5.3 Braile Biomedica Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Braile Biomedica Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Braile Biomedica Recent Developments
11.6 CryoLife, Inc
11.6.1 CryoLife, Inc Company Information
11.6.2 CryoLife, Inc Overview
11.6.3 CryoLife, Inc Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 CryoLife, Inc Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CryoLife, Inc Recent Developments
11.7 Meril Life Sciences Pvt. Ltd
11.7.1 Meril Life Sciences Pvt. Ltd Company Information
11.7.2 Meril Life Sciences Pvt. Ltd Overview
11.7.3 Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Meril Life Sciences Pvt. Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Stented Tissue Heart Valve Industry Chain Analysis
12.2 Stented Tissue Heart Valve Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Stented Tissue Heart Valve Production Mode & Process
12.4 Stented Tissue Heart Valve Sales and Marketing
12.4.1 Stented Tissue Heart Valve Sales Channels
12.4.2 Stented Tissue Heart Valve Distributors
12.5 Stented Tissue Heart Valve Customers
13 Stented Tissue Heart Valve Market Dynamics
13.1 Stented Tissue Heart Valve Industry Trends
13.2 Stented Tissue Heart Valve Market Drivers
13.3 Stented Tissue Heart Valve Market Challenges
13.4 Stented Tissue Heart Valve Market Restraints
14 Key Findings in the Global Stented Tissue Heart Valve Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Stented Tissue Heart Valve market is projected to grow from US$ 376 million in 2025 to US$ 682 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 136
USD 4900.00
(Single User License)
The global Stented Tissue Heart Valve market size was US$ 376 million in 2025 and is forecast to reach a readjusted size of US$ 682 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 76
USD 4250.00
(Single User License)
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 376 million in 2025 and is projected to reach US$ 682 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 93
USD 3950.00
(Single User License)
The global Stented Tissue Heart Valve market was valued at US$ 376 million in 2025 and is anticipated to reach US$ 682 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 116
USD 2900.00
(Single User License)
The global Stented Tissue Heart Valve market size was US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
The global Stented Tissue Heart Valve market is projected to grow from US$ 348 million in 2024 to US$ 631 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 139
USD 4900.00
(Single User License)
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 96
USD 3950.00
(Single User License)
The global market for Stented Tissue Heart Valve was valued at US$ 348 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
The global Stented Tissue Heart Valve revenue was US$ 320 million in 2023 and is forecast to a readjusted size of US$ 584 million by 2030 with a CAGR of 9.0% during the review period (2024-2030).
Published Date: 2024-12-26
Pages: 107
USD 4350.00
(Single User License)
The global market for Stented Tissue Heart Valve was valued at US$ 320 million in the year 2023 and is projected to reach a revised size of US$ 584 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2024-12-26
Pages: 78
USD 2900.00
(Single User License)
The global Stented Tissue Heart Valve market is projected to grow from US$ 376 million in 2025 to US$ 682 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 136
The global Stented Tissue Heart Valve market size was US$ 376 million in 2025 and is forecast to reach a readjusted size of US$ 682 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 76
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 376 million in 2025 and is projected to reach US$ 682 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 93
The global Stented Tissue Heart Valve market was valued at US$ 376 million in 2025 and is anticipated to reach US$ 682 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 116
The global Stented Tissue Heart Valve market size was US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
The global Stented Tissue Heart Valve market is projected to grow from US$ 348 million in 2024 to US$ 631 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 139
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 96
The global market for Stented Tissue Heart Valve was valued at US$ 348 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-03-10
Pages: 87
The global Stented Tissue Heart Valve revenue was US$ 320 million in 2023 and is forecast to a readjusted size of US$ 584 million by 2030 with a CAGR of 9.0% during the review period (2024-2030).
Published: 2024-12-26
Pages: 107
The global market for Stented Tissue Heart Valve was valued at US$ 320 million in the year 2023 and is projected to reach a revised size of US$ 584 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Published: 2024-12-26
Pages: 78
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now